YMAB | | Y-mAbs Therapeutics, Inc. | Rajah Vignesh | SVP & CHIEF MEDICAL OFFICER | Mar 05, 2024 | Sale | $16.53 | 1,711 | 28,283 | 33,889 | Mar 07, 2024, 05:02 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | CHIEF BUSINESS OFFICER | Mar 05, 2024 | Sale | $16.44 | 3,900 | 64,116 | 158,700 | Mar 07, 2024, 05:01 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Smith Susan Laura | SVP & CHIEF COMMERCIAL OFFICER | Mar 05, 2024 | Sale | $16.55 | 1,682 | 27,837 | 33,918 | Mar 07, 2024, 04:59 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | Dec 21, 2023 | Option Exercise | $2.00 | 50,000 | 100,000 | 140,500 | Dec 26, 2023, 04:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | Dec 13, 2023 | Sale | $6.58 | 50,000 | 329,000 | 365,032 | Dec 15, 2023, 07:40 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | Dec 14, 2023 | Sale | $6.83 | 50,000 | 341,500 | 315,032 | Dec 15, 2023, 07:40 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | Dec 15, 2023 | Sale | $6.61 | 50,000 | 330,500 | 265,032 | Dec 15, 2023, 07:40 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Dec 11, 2023 | Buy | $6.85 | 6,455 | 44,232 | 4,559,233 | Dec 12, 2023, 08:27 AM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Dec 11, 2023 | Buy | $6.85 | 6,455 | 44,232 | 4,559,233 | Dec 12, 2023, 08:26 AM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Dec 07, 2023 | Buy | $6.50 | 6,183 | 40,190 | 4,431,412 | Dec 11, 2023, 05:25 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Dec 08, 2023 | Buy | $6.99 | 18,503 | 129,379 | 4,449,915 | Dec 11, 2023, 05:25 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Dec 11, 2023 | Buy | $7.01 | 102,863 | 720,843 | 4,552,778 | Dec 11, 2023, 05:25 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Dec 08, 2023 | Buy | $6.99 | 18,503 | 129,379 | 4,449,915 | Dec 11, 2023, 05:25 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Dec 11, 2023 | Buy | $7.01 | 102,863 | 720,843 | 4,552,778 | Dec 11, 2023, 05:25 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Dec 07, 2023 | Buy | $6.50 | 6,183 | 40,190 | 4,431,412 | Dec 11, 2023, 05:25 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Nov 29, 2023 | Buy | $5.97 | 51,837 | 309,477 | 4,425,229 | Dec 01, 2023, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Nov 29, 2023 | Buy | $5.97 | 51,837 | 309,477 | 4,425,229 | Dec 01, 2023, 05:14 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Nov 27, 2023 | Buy | $5.49 | 62,516 | 343,019 | 4,342,721 | Nov 29, 2023, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Nov 28, 2023 | Buy | $5.81 | 30,671 | 178,275 | 4,373,392 | Nov 29, 2023, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Nov 27, 2023 | Buy | $5.49 | 62,516 | 343,019 | 4,342,721 | Nov 29, 2023, 05:14 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Nov 28, 2023 | Buy | $5.81 | 30,671 | 178,275 | 4,373,392 | Nov 29, 2023, 05:14 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | May 15, 2023 | Buy | $9.65 | 101,740 | 981,404 | 4,280,205 | May 17, 2023, 05:07 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | May 15, 2023 | Buy | $9.65 | 101,740 | 981,404 | 4,280,205 | May 17, 2023, 05:05 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Rajah Vignesh | SVP & CMO | Nov 15, 2022 | Buy | $4.92 | 1,195 | 5,884 | 4,266 | Nov 16, 2022, 07:01 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Feb 22, 2022 | Sale | $7.85 | 4,000 | 31,400 | 181,077 | Feb 23, 2022, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 07, 2022 | Sale | $7.59 | 91,031 | 691,180 | 755,171 | Feb 09, 2022, 06:59 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 08, 2022 | Sale | $7.01 | 125,863 | 882,891 | 629,308 | Feb 09, 2022, 06:59 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 09, 2022 | Sale | $6.96 | 64,276 | 447,117 | 565,032 | Feb 09, 2022, 06:59 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas | Feb 04, 2022 | Sale | $7.97 | 4,000 | 31,880 | 185,077 | Feb 07, 2022, 05:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 04, 2022 | Sale | $7.70 | 101,104 | 778,531 | 846,202 | Feb 07, 2022, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 03, 2022 | Sale | $7.90 | 35,060 | 277,027 | 947,306 | Feb 07, 2022, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 01, 2022 | Option Exercise | $6.07 | 16,000 | 97,161 | 58,000 | Feb 03, 2022, 05:00 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 24, 2022 | Sale | $10.63 | 88,055 | 936,412 | 1,038,149 | Jan 26, 2022, 05:09 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Jan 24, 2022 | Sale | $9.84 | 4,000 | 39,360 | 189,077 | Jan 25, 2022, 05:01 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 21, 2022 | Sale | $10.75 | 70,318 | 755,815 | 1,090,605 | Jan 24, 2022, 05:39 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 20, 2022 | Sale | $11.33 | 112,767 | 1,277,289 | 1,140,739 | Jan 24, 2022, 05:39 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 18, 2022 | Sale | $6.77 | 16,000 | 108,314 | 58,000 | Jan 20, 2022, 05:13 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 18, 2022 | Sale | $11.46 | 400 | 4,584 | 1,322,920 | Jan 20, 2022, 05:13 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 19, 2022 | Sale | $10.89 | 69,414 | 756,092 | 1,253,506 | Jan 20, 2022, 05:13 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Jan 04, 2022 | Sale | $17.12 | 4,000 | 68,480 | 193,077 | Jan 05, 2022, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Dec 22, 2021 | Sale | $16.36 | 4,000 | 65,440 | 197,077 | Dec 23, 2021, 04:55 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Dec 06, 2021 | Sale | $16.48 | 44,000 | 725,242 | 1,397,320 | Dec 08, 2021, 05:18 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Dec 07, 2021 | Sale | $17.58 | 10,000 | 175,832 | 1,383,320 | Dec 08, 2021, 05:18 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Dec 06, 2021 | Sale | $16.35 | 4,000 | 65,400 | 201,077 | Dec 07, 2021, 05:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Nov 30, 2021 | Sale | $17.06 | 25,170 | 429,458 | 1,461,890 | Dec 01, 2021, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Nov 29, 2021 | Sale | $17.16 | 22,437 | 385,026 | 1,462,490 | Dec 01, 2021, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Nov 23, 2021 | Sale | $9.53 | 100,000 | 952,850 | 100,000 | Nov 26, 2021, 05:33 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Nov 22, 2021 | Sale | $18.09 | 4,000 | 72,360 | 205,077 | Nov 23, 2021, 05:06 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Nov 16, 2021 | Sale | $19.33 | 4,000 | 77,302 | 1,484,927 | Nov 18, 2021, 05:18 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Nov 04, 2021 | Sale | $27.54 | 4,000 | 110,160 | 209,077 | Nov 05, 2021, 05:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Oct 29, 2021 | Sale | $24.82 | 4,000 | 99,261 | 1,488,927 | Nov 01, 2021, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Oct 22, 2021 | Sale | $25.94 | 4,000 | 103,760 | 213,077 | Oct 26, 2021, 06:04 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Oct 15, 2021 | Sale | $27.20 | 4,000 | 108,799 | 1,492,927 | Oct 19, 2021, 05:17 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Oct 04, 2021 | Sale | $28.78 | 4,000 | 115,120 | 217,077 | Oct 05, 2021, 05:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Sep 30, 2021 | Sale | $28.26 | 4,000 | 113,054 | 1,496,927 | Oct 04, 2021, 05:17 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Sep 22, 2021 | Sale | $30.82 | 4,000 | 123,280 | 221,077 | Sep 23, 2021, 05:15 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Sep 15, 2021 | Sale | $33.64 | 4,000 | 134,579 | 1,500,927 | Sep 17, 2021, 05:20 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Sep 07, 2021 | Sale | $32.03 | 4,000 | 128,120 | 225,077 | Sep 08, 2021, 05:31 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Sep 02, 2021 | Sale | $33.18 | 50,000 | 1,658,915 | 1,504,927 | Sep 07, 2021, 05:30 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Sep 07, 2021 | Option Exercise | $2.00 | 50,000 | 100,000 | 50,000 | Sep 07, 2021, 05:30 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Aug 23, 2021 | Sale | $28.60 | 4,000 | 114,400 | 229,077 | Aug 24, 2021, 05:02 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Aug 13, 2021 | Sale | $31.01 | 1,110 | 34,426 | 1,582,817 | Aug 17, 2021, 06:32 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Aug 16, 2021 | Sale | $29.30 | 26,111 | 765,071 | 1,578,817 | Aug 17, 2021, 06:32 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Aug 17, 2021 | Sale | $28.96 | 1,779 | 51,527 | 1,554,927 | Aug 17, 2021, 06:32 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Rajah Vignesh | SVP & CMO | Aug 12, 2021 | Buy | $29.95 | 1,374 | 41,147 | 3,071 | Aug 13, 2021, 05:41 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Aug 04, 2021 | Sale | $33.72 | 4,000 | 134,880 | 233,077 | Aug 05, 2021, 05:20 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Aug 03, 2021 | Sale | $33.73 | 4,000 | 134,927 | 1,583,927 | Aug 05, 2021, 05:18 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Jul 22, 2021 | Sale | $34.50 | 4,000 | 138,000 | 237,077 | Jul 26, 2021, 06:19 AM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jul 20, 2021 | Sale | $32.47 | 4,000 | 129,875 | 1,587,927 | Jul 21, 2021, 06:56 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jul 07, 2021 | Sale | $31.87 | 4,000 | 127,465 | 1,591,927 | Jul 08, 2021, 05:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Jul 06, 2021 | Sale | $34.15 | 4,000 | 136,600 | 241,077 | Jul 07, 2021, 06:00 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jun 30, 2021 | Sale | $33.86 | 4,000 | 135,446 | 1,595,927 | Jul 02, 2021, 04:31 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Jun 22, 2021 | Sale | $36.17 | 4,000 | 144,680 | 245,077 | Jun 23, 2021, 04:30 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Jun 08, 2021 | Sale | $35.28 | 33,300 | 1,174,694 | 4,306,394 | Jun 10, 2021, 07:00 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Director | Jun 09, 2021 | Sale | $36.19 | 116,700 | 4,223,116 | 4,189,694 | Jun 10, 2021, 07:00 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Jun 08, 2021 | Sale | $35.28 | 33,300 | 1,174,694 | 4,306,394 | Jun 10, 2021, 06:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Jun 09, 2021 | Sale | $36.19 | 116,700 | 4,223,116 | 4,189,694 | Jun 10, 2021, 06:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | 10% Owner | Jun 07, 2021 | Sale | $34.15 | 72,400 | 2,472,583 | 4,339,694 | Jun 09, 2021, 06:51 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Jun 07, 2021 | Sale | $34.15 | 72,400 | 2,472,583 | 4,339,694 | Jun 09, 2021, 06:49 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | 10% Owner | Jun 03, 2021 | Sale | $33.19 | 30,666 | 1,017,670 | 4,415,935 | Jun 07, 2021, 04:30 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | 10% Owner | Jun 04, 2021 | Sale | $34.03 | 3,841 | 130,704 | 4,412,094 | Jun 07, 2021, 04:30 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, Secretary & Treas. | Jun 04, 2021 | Sale | $33.48 | 4,000 | 133,920 | 249,077 | Jun 07, 2021, 04:30 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | May 28, 2021 | Sale | $36.34 | 25,000 | 908,475 | 4,453,465 | Jun 02, 2021, 04:32 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Director | Jun 01, 2021 | Sale | $35.57 | 6,864 | 244,173 | 4,446,601 | Jun 02, 2021, 04:32 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | May 28, 2021 | Sale | $36.95 | 4,000 | 147,813 | 1,603,927 | Jun 01, 2021, 04:32 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Apr 12, 2021 | Option Exercise | $14.30 | 14,000 | 200,253 | 7,000 | Apr 14, 2021, 05:00 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Apr 12, 2021 | Sale | $26.60 | 4,000 | 106,388 | 1,611,927 | Apr 14, 2021, 05:00 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Apr 01, 2021 | Sale | $30.27 | 6,000 | 181,615 | 1,615,927 | Apr 05, 2021, 04:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Apr 01, 2021 | Sale | $16.13 | 18,000 | 290,331 | 9,000 | Apr 05, 2021, 04:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Mar 15, 2021 | Option Exercise | $19.40 | 14,000 | 271,554 | 7,000 | Mar 17, 2021, 04:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Mar 15, 2021 | Sale | $36.78 | 4,000 | 147,102 | 1,621,927 | Mar 17, 2021, 04:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Mar 01, 2021 | Sale | $18.76 | 18,000 | 337,611 | 9,000 | Mar 03, 2021, 12:00 AM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Mar 01, 2021 | Sale | $35.50 | 6,000 | 213,029 | 596,000 | Mar 03, 2021, 12:00 AM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 16, 2021 | Option Exercise | $24.54 | 14,000 | 343,556 | 7,000 | Feb 18, 2021, 04:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 16, 2021 | Sale | $47.09 | 4,000 | 188,367 | 602,000 | Feb 18, 2021, 04:35 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 01, 2021 | Option Exercise | $21.99 | 14,000 | 307,897 | 7,000 | Feb 03, 2021, 05:50 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Feb 01, 2021 | Sale | $41.97 | 4,000 | 167,888 | 606,000 | Feb 03, 2021, 05:50 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 19, 2021 | Sale | $46.56 | 4,000 | 186,230 | 610,000 | Jan 21, 2021, 04:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | Gad Thomas | See remarks | Jan 19, 2021 | Sale | $24.25 | 14,000 | 339,563 | 7,000 | Jan 21, 2021, 04:16 PM |
YMAB | | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Jan 19, 2021 | Sale | $28.84 | 4,000 | 115,365 | 2,000 | Jan 20, 2021, 04:16 PM |